151 related articles for article (PubMed ID: 32948569)
1. Comprehensive Cervical Cancer Prevention in Tanzania (CONCEPT) study: Cohort profile.
Mchome B; Swai P; Wu C; Katanga J; Kahesa C; Manongi R; Mwaiselage JD; Kjaer S; Rasch V; Linde DS
BMJ Open; 2020 Sep; 10(9):e038531. PubMed ID: 32948569
[TBL] [Abstract][Full Text] [Related]
2. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
3. Comparison of human papillomavirus-based cervical cancer screening strategies in Tanzania among women with and without HIV.
Kahesa C; Thomsen LT; Linde DS; Mchome B; Katanga J; Swai P; Manongi R; Kjaerem M; Iftner T; Waldstrøm M; Mwaiselage J; Rasch V; Kjaer SK
Int J Cancer; 2023 Feb; 152(4):686-696. PubMed ID: 36093587
[TBL] [Abstract][Full Text] [Related]
4. Performance of HPV testing, Pap smear and VIA in women attending cervical cancer screening in Kilimanjaro region, Northern Tanzania: a cross-sectional study nested in a cohort.
Mremi A; Mchome B; Mlay J; Schledermann D; Blaakær J; Rasch V
BMJ Open; 2022 Oct; 12(10):e064321. PubMed ID: 36316070
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women.
Baldur-Felskov B; Mwaiselage J; Faber MT; Kjaerem M; de la Cour CD; Munk C; Kahesa C; Iftner T; Rasch V; Kjaer SK
Trop Med Int Health; 2019 Feb; 24(2):229-237. PubMed ID: 30444556
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
[TBL] [Abstract][Full Text] [Related]
7. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
[TBL] [Abstract][Full Text] [Related]
8. Acceptability and feasibility of self-sampling and follow-up attendance after text message delivery of human papillomavirus results: A cross-sectional study nested in a cohort in rural Tanzania.
Mremi A; Linde DS; Mchome B; Mlay J; Schledermann D; Blaakaer J; Rasch V
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):802-810. PubMed ID: 33555038
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study.
Dartell M; Rasch V; Kahesa C; Mwaiselage J; Ngoma T; Junge J; Gernow A; Ejlersen SF; Munk C; Iftner T; Kjaer SK
Sex Transm Dis; 2012 Mar; 39(3):201-8. PubMed ID: 22337107
[TBL] [Abstract][Full Text] [Related]
10. HPV types, cervical high-grade lesions and risk factors for oncogenic human papillomavirus infection among 3416 Tanzanian women.
Mchome BL; Kjaer SK; Manongi R; Swai P; Waldstroem M; Iftner T; Wu C; Mwaiselage J; Rasch V
Sex Transm Infect; 2021 Feb; 97(1):56-62. PubMed ID: 32269071
[TBL] [Abstract][Full Text] [Related]
11. Agreement between careHPV and hybrid capture 2 in detecting high-risk HPV in women in Tanzania.
Katanga J; Kjaer SK; Manongi R; Pembe AB; Iftner T; Waldstrom M; Mwaiselage J; Rasch V
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):786-793. PubMed ID: 33497480
[TBL] [Abstract][Full Text] [Related]
12. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
[TBL] [Abstract][Full Text] [Related]
13. The association between human papillomavirus and cervical high-grade cytology among HIV-positive and HIV-negative Tanzanian women: A cross-sectional study.
Swai P; Kjaer SK; Mchome B; Manongi R; Msuya SE; Wu CS; Waldstrom M; Iftner T; Mwaiselage J; Rasch V
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):775-785. PubMed ID: 33512002
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for high-risk human papillomavirus detection among HIV-negative and HIV-positive women from Tanzania.
Dartell M; Rasch V; Munk C; Kahesa C; Mwaiselage J; Iftner T; Kjaer SK
Sex Transm Dis; 2013 Sep; 40(9):737-43. PubMed ID: 23949589
[TBL] [Abstract][Full Text] [Related]
15. Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK.
Cicconi P; Wells C; McCarthy B; Wareing S; Andersson MI; Fox J; Lwanga J; Pal N; Burns F; Woodward C; Malek R; Sabin CA; Dorrell L
HIV Med; 2022 Apr; 23(4):390-396. PubMed ID: 35243750
[TBL] [Abstract][Full Text] [Related]
16. "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
Bakiewicz A; Rasch V; Mwaiselage J; Linde DS
BMC Womens Health; 2020 Mar; 20(1):65. PubMed ID: 32234028
[TBL] [Abstract][Full Text] [Related]
17. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
19. Self-collected vaginal sampling for the detection of genital human papillomavirus (HPV) using careHPV among Ghanaian women.
Obiri-Yeboah D; Adu-Sarkodie Y; Djigma F; Hayfron-Benjamin A; Abdul L; Simpore J; Mayaud P
BMC Womens Health; 2017 Sep; 17(1):86. PubMed ID: 28950841
[TBL] [Abstract][Full Text] [Related]
20. Performance of careHPV, hybrid capture 2 and visual inspection with acetic acid for detection of high-grade cervical lesion in Tanzania: A cross-sectional study.
Katanga J; Kjaer SK; Manongi R; Wu CS; Iftner T; Waldstrom M; Pembe AB; Mwaiselage J; Rasch V
PLoS One; 2019; 14(6):e0218559. PubMed ID: 31216333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
